// App-Quantinova.ai

55 : Phosphodiesterase type 5 inhibitors (PDE5i) and prostate cancer recurrence.

Researchers

Presenter

  • Stacy Loeb

Principal Investigators

  • Yasin Folkvaljon

  • David Robinson

  • Thorsten Schlomm

  • Hans Garmo

  • Pr Stattin

Medical Centers

  • New York University Medical Center, New York City, NY

  • Uppsala University Hospital, Uppsala, Sweden

  • Umeå University Hospital, Umeå, Sweden

  • Martini-Clinic Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany

  • Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, United Kingdom

  • Umea University, Umea, Sweden

Locations

  • United States

  • Sweden

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved